The Measures for Improved Availability of medicines and vaccines (MIA) project and a sister COVID-project were funded by the Research Council of Norway HELSEVEL and GLOBVAC programs respectively.
Ensuring availability of essential medicines, vaccines and health commodities is a critical societal challenge. The purpose of MIA is to help key stakeholders make evidence-based decisions that sustainably reduce shortages ensuring future health and care services. This conference presents key insights and research findings from the MIA research team: BI Norwegian Business School, the Norwegian Institute of Public Health, INSEAD Business School, Lancaster University, Rotterdam School of Management, Jimma University, Institute of Health and St.Paul's Hospital Millennium Medical Colleges.
Through engaging talks and interactive sessions, you will see how pharmaceutical and health commodity supply chains could be strengthened through the application of system-wide approaches. Using qualitative and quantitative methods/modelling of the networks, the research team compared different forms of supply chain preparedness to see what works best under different circumstances, with the aim to design supply chains that function as intended both under normal conditions and in crises.
The event will be held in English, while some of the parallel tracks and workshops will be held in Norwegian. See programme for more information.
Organisers: BI Norwegian Business School, Norwegian Institute of Public Health, RSM Erasmus, Lancaster University Management School, INSEAD, St. Paul’s Hospital Millennium Medical College, Jimma University, The Research Council of Norway